# Genomma Lab Internacional (LABB.MX)

Canonical: https://gigainvestors.com/s/LABB.MX

Analysis as of: 2026-10-16T07:45:13.840Z. Financial observations: FY2005–FY2025.

Listing currency: MXN. Reporting currency: MXN.

## Verdict

Not a wonderful business

Quality tests for Buy: not passed (profit record: pass; earnings resilience is evidence only). Published buy qualification: no.

Share price: MXN 13.78 per share; close as of 2026-10-15.

Estimated value: low MXN 15.88 per share, central MXN 20.69 per share, high MXN 22.82 per share. Buy at or below the central value MXN 20.69 per share. Valuation as of 2026-10-16T07:45:13.840Z; scenarios are not confidence intervals.

Expected annual return: 18.9% at the stated quote. About 18.9% a year at today's price (required return 13.3%). required return 13.3% a year (MX 10-year bond 9.3% + 4 points).

## Checklist

### understandable: pass

- 3 revenue declines in the last 10 years (informational)

- Financial history: 10 years

- Years with declining revenue: 3

- Years with a net loss: 1

- Operating margin variation: 0.29×

Chart: Operating margin; fiscal year observations.

- FY2016: 0.03×

- FY2017: 0.21×

- FY2018: 0.19×

- FY2019: 0.18×

- FY2020: 0.21×

- FY2021: 0.19×

- FY2022: 0.19×

- FY2023: 0.19×

- FY2024: 0.21×

- FY2025: 0.21×

### moat: fail

- ROIC median below threshold

- ROIC, median of available years: 13.9%

- ROIC, second-lowest year: 12.0%

- Typical minus recent gross margin: 0.4 pp

- Typical gross margin (annual median): 63.3%

- Recent gross margin (lower of latest and 3-year median): 62.8%

- Years with nonpositive capital: 0

- Capital spending / revenue: 3.0%

- ROIC including acquisitions, ten-year median: 8.6%

Chart: ROIC excluding acquisitions; fiscal year observations.

- FY2016: 2.1%

- FY2017: 15.5%

- FY2018: 12.0%

- FY2019: 12.2%

- FY2020: 13.7%

- FY2021: 13.1%

- FY2022: 14.2%

- FY2023: 14.9%

- FY2024: 18.2%

- FY2025: 16.2%

### economics: pass

- Owner earnings / net income, 5-yr: 1.05×

- Cash conversion uses consolidated totals: No

- Owner earnings, five-year total: MXN 7.2B

- Net income, five-year total: MXN 6.8B

- Return on incremental invested capital: 71.0%

- Working capital / revenue, annual change: -2.4 pp

- Working capital / revenue, change between three-year averages: -16.9 pp

- Working capital / revenue, final three-year average: 25.4%

Chart: Annual owner cash / profit; fiscal year observations.

- FY2021: 0.89×

- FY2022: 0.99×

- FY2023: 1.15×

- FY2024: 0.99×

- FY2025: 1.21×

### management: pass

- Historical market-dollar context (not the management verdict): 2016 to 2025 (9 years)

- potential debt-funded buybacks (informational)

- buybacks leaned toward cheaper years (informational)

- ROIC first 3 years vs last 3 years: 12.0% vs 16.2%

- Per-share earnings: 1.09 to 1.53 (three-year endpoint medians)

- Management verdict uses per-share economic progress: Yes

- Ordinary dilution, 5-year annual growth: -0.8%

- Market cap gain: MXN -3.3B

- Cumulative retained earnings: MXN 6.7B

- Diluted shares, 5-year annual growth: -0.8%

- $1 test, starting fiscal year: FY2016

- $1 test, ending fiscal year: FY2025

- Per-share value growth: 4.9%

- Per-share value change: MXN 0.44

- Per-share value, starting three-year median: MXN 1.09

- Per-share value, ending three-year median: MXN 1.53

- Buybacks concentrated in cheaper years (correlation): 0.31

- Average buyback yield: 4.5%

- Buyback history: 10 years

- Debt-funded buybacks: Yes

- Acquisition spending: MXN 466M

- Cumulative net income, 10 years: MXN 9.8B

- ROIC, first three-year median: 12.0%

- ROIC, last three-year median: 16.2%

Chart: Earnings per share; fiscal year observations.

- FY2016: MXN -1.74

- FY2017: MXN 1.22

- FY2018: MXN 1.09

- FY2019: MXN 0.75

- FY2020: MXN 1.44

- FY2021: MXN 1.30

- FY2022: MXN 1.40

- FY2023: MXN 1.07

- FY2024: MXN 1.53

- FY2025: MXN 1.65

### accounting: pass

- Sloan accruals: -1.8%

- Receivables to sales index (DSRI): 1.07×

- Restructuring years, last five: 0

- Earnings backed by cash: Yes

- Operating cash / earnings: 1.27×

- Accounting red flags: 0

- Goodwill and intangibles / equity: 0.50×

Chart: Sloan accruals; fiscal year observations.

- FY2016: -20.5%

- FY2017: -0.7%

- FY2018: -2.5%

- FY2019: -1.3%

- FY2020: -1.1%

- FY2021: -0.7%

- FY2022: -3.1%

- FY2023: -3.6%

- FY2024: -6.4%

- FY2025: -1.8%

## Holders

## Price story

Down 51% since Jan 2025 · sales -5.7%

Story as of 2026-10-16T10:00:13.366Z; price observation 2026-10-15.

Price needs cash profits to grow 0.2% a year for ten years

### Sales · FY2024–2025

sales -5.7%; source https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/; observed 2026-10-16.

- FY2016: MXN 11B 

- FY2017: MXN 12B 

- FY2018: MXN 12B 

- FY2019: MXN 13B 

- FY2020: MXN 14B 

- FY2021: MXN 15B 

- FY2022: MXN 17B 

- FY2023: MXN 16B 

- FY2024: MXN 19B 

- FY2025: MXN 18B 

### Gross margin · FY2025

gross margin 62.8%; source https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/; observed 2026-10-16.

- FY2016: 67.9% 

- FY2017: 67.2% 

- FY2018: 65.8% 

- FY2019: 63.7% 

- FY2020: 61.9% 

- FY2021: 61.7% 

- FY2022: 60.4% 

- FY2023: 61.2% 

- FY2024: 64.1% 

- FY2025: 62.8% 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in drug manufacturers specialty & generic; annual sales are MXN 17.5 billion.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2025-12-31 (filed 2026-10-16T07:45:13.840Z); FY2025: revenue 17541157000; grossProfit 11022132000; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); LABB.MX: Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

### Why customers stay

Margins ranged from 61.2% to 64.1% during 2023–25; it earns 13.9% on its capital.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2023-12-31 (filed 2026-10-16T07:45:13.840Z); FY2023: grossProfit / revenue = 61.2%.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2024-12-31 (filed 2026-10-16T07:45:13.840Z); FY2024: grossProfit / revenue = 64.1%.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2025-12-31 (filed 2026-10-16T07:45:13.840Z); FY2025: grossProfit / revenue = 62.8%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); 10-year return on capital observations [[2016,0.0214234255186203],[2017,0.15498032459058345],[2018,0.11987577448563697],[2019,0.12238347625740191],[2020,0.1365262719687176],[2021,0.13133620344529556],[2022,0.14223153823916884],[2023,0.14934409635406948],[2024,0.18204290502068135],[2025,0.1616959171108379]]; median 0.13937890510394324. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Can it raise prices

Kept about a 60% gross margin through 2022 cost inflation.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); Gross margin observations: [[2021,0.6174960655861129],[2022,0.6042568474793447],[2023,0.6123245792860272]]; range within 2 percentage points.

### Where the cash goes

Reinvests 7.4% of cash earnings; earns 71% on new investment.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); FY2016: growth capex 0; upkeep 158117000; owner earnings 1385346000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2017-12-31 (filed 2026-10-16T07:45:13.840Z); FY2017: growth capex 0; upkeep 262877000; owner earnings 1129495000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2019-12-31 (filed 2026-10-16T07:45:13.840Z); FY2019: growth capex 160442876.1916449; upkeep 685502123.8083551; owner earnings 208124876.1916449. Growth capex / owner earnings = 0.7708971610097507.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2020-12-31 (filed 2026-10-16T07:45:13.840Z); FY2020: growth capex 220063081.4383738; upkeep 476788918.5616262; owner earnings 1141057681.4383738. Growth capex / owner earnings = 0.19285885807365205.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2021-12-31 (filed 2026-10-16T07:45:13.840Z); FY2021: growth capex 322125573.9484048; upkeep 308083426.0515952; owner earnings 1158742573.9484048. Growth capex / owner earnings = 0.277995804409572.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2022-12-31 (filed 2026-10-16T07:45:13.840Z); FY2022: growth capex 175837000; upkeep 227125000; owner earnings 1376480400. Growth capex / owner earnings = 0.1277439184749743.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2023-12-31 (filed 2026-10-16T07:45:13.840Z); FY2023: growth capex 0; upkeep 59722000; cash acquisitions 0; owner earnings 1184488200. Growth capex plus acquisitions / owner earnings = 0.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2024-12-31 (filed 2026-10-16T07:45:13.840Z); FY2024: growth capex 315445000; upkeep 359586000; cash acquisitions 0; owner earnings 1481522400. Growth capex plus acquisitions / owner earnings = 0.2129194941635712.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2025-12-31 (filed 2026-10-16T07:45:13.840Z); FY2025: growth capex 0; upkeep 26690000; cash acquisitions 144187000; owner earnings 1954774600. Growth capex plus acquisitions / owner earnings = 0.07376144543723864.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); Incremental return on capital 0.7101288814513709, from the economics test's unchanged annual inputs.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); Dividend observations: [[2016,0],[2017,0],[2018,391756000],[2019,391756000],[2020,391756000],[2021,391756000],[2022,777663000],[2023,580704000],[2024,778819000],[2025,781772000]]. Zero only counted when supported by a complete cash-flow statement.

- Source: https://eodhd.com/api/fundamentals/GEKA.F.json#2025-12-31 (filed 2026-10-16T07:45:13.840Z); FY2025: cash repurchases 1875152000 MXN.

### Are managers owners

Insiders own 31.1% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); LABB.MX SharesStats.PercentInsiders = 31.05 percentage points; cache date 2026-10-16.

### What the price says

The price assumes cash profits grow 0.2% yearly over ten years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:45:13.840Z); Ten-year compound average after fade. Initial solved rate -0.01046465273509184. Price 13.78; FX 1; discount 0.13252; same standard ten-year fade to terminal 0.03.  Closing-price date 2026-10-15.

## Monthly share-price history (MXN per share)

- 2016-10: MXN 22.61 per share

- 2016-11: MXN 21.99 per share

- 2016-12: MXN 21.52 per share

- 2017-01: MXN 21.88 per share

- 2017-02: MXN 23.09 per share

- 2017-03: MXN 22.35 per share

- 2017-04: MXN 23.75 per share

- 2017-05: MXN 23.36 per share

- 2017-06: MXN 23.36 per share

- 2017-07: MXN 22.89 per share

- 2017-08: MXN 22.91 per share

- 2017-09: MXN 23.38 per share

- 2017-10: MXN 22.37 per share

- 2017-11: MXN 22.08 per share

- 2017-12: MXN 20.52 per share

- 2018-01: MXN 20.45 per share

- 2018-02: MXN 20.39 per share

- 2018-03: MXN 19.70 per share

- 2018-04: MXN 18.19 per share

- 2018-05: MXN 16.90 per share

- 2018-06: MXN 16.59 per share

- 2018-07: MXN 14.87 per share

- 2018-08: MXN 16.54 per share

- 2018-09: MXN 16.39 per share

- 2018-10: MXN 13.05 per share

- 2018-11: MXN 12.53 per share

- 2018-12: MXN 11.67 per share

- 2019-01: MXN 13.26 per share

- 2019-02: MXN 12.73 per share

- 2019-03: MXN 13.97 per share

- 2019-04: MXN 15.24 per share

- 2019-05: MXN 16.50 per share

- 2019-06: MXN 17.42 per share

- 2019-07: MXN 17.48 per share

- 2019-08: MXN 16.79 per share

- 2019-09: MXN 18.92 per share

- 2019-10: MXN 20.31 per share

- 2019-11: MXN 18.23 per share

- 2019-12: MXN 18.58 per share

- 2020-01: MXN 22.35 per share

- 2020-02: MXN 19.92 per share

- 2020-03: MXN 18.87 per share

- 2020-04: MXN 19.41 per share

- 2020-05: MXN 20.21 per share

- 2020-06: MXN 23.47 per share

- 2020-07: MXN 23.50 per share

- 2020-08: MXN 22.96 per share

- 2020-09: MXN 21.64 per share

- 2020-10: MXN 18.81 per share

- 2020-11: MXN 19.75 per share

- 2020-12: MXN 18.84 per share

- 2021-01: MXN 20.99 per share

- 2021-02: MXN 20.99 per share

- 2021-03: MXN 20.61 per share

- 2021-04: MXN 20.24 per share

- 2021-05: MXN 20.94 per share

- 2021-06: MXN 20.57 per share

- 2021-07: MXN 19.34 per share

- 2021-08: MXN 19.43 per share

- 2021-09: MXN 19.59 per share

- 2021-10: MXN 19.70 per share

- 2021-11: MXN 17.95 per share

- 2021-12: MXN 21.48 per share

- 2022-01: MXN 20.49 per share

- 2022-02: MXN 18.68 per share

- 2022-03: MXN 21.85 per share

- 2022-04: MXN 21.49 per share

- 2022-05: MXN 19.85 per share

- 2022-06: MXN 20.13 per share

- 2022-07: MXN 18.95 per share

- 2022-08: MXN 16.47 per share

- 2022-09: MXN 13.90 per share

- 2022-10: MXN 15.25 per share

- 2022-11: MXN 15.55 per share

- 2022-12: MXN 16.87 per share

- 2023-01: MXN 17.78 per share

- 2023-02: MXN 14.71 per share

- 2023-03: MXN 14.51 per share

- 2023-04: MXN 14.93 per share

- 2023-05: MXN 14.95 per share

- 2023-06: MXN 13.18 per share

- 2023-07: MXN 15.01 per share

- 2023-08: MXN 14.02 per share

- 2023-09: MXN 13.40 per share

- 2023-10: MXN 13.42 per share

- 2023-11: MXN 14.16 per share

- 2023-12: MXN 14.14 per share

- 2024-01: MXN 14.09 per share

- 2024-02: MXN 13.19 per share

- 2024-03: MXN 15.69 per share

- 2024-04: MXN 16.62 per share

- 2024-05: MXN 17.71 per share

- 2024-06: MXN 17.18 per share

- 2024-07: MXN 19.15 per share

- 2024-08: MXN 18.99 per share

- 2024-09: MXN 22.65 per share

- 2024-10: MXN 26.80 per share

- 2024-11: MXN 27.00 per share

- 2024-12: MXN 25.34 per share

- 2025-01: MXN 28.17 per share

- 2025-02: MXN 25.78 per share

- 2025-03: MXN 25.33 per share

- 2025-04: MXN 22.92 per share

- 2025-05: MXN 22.42 per share

- 2025-06: MXN 20.45 per share

- 2025-07: MXN 21.78 per share

- 2025-08: MXN 22.32 per share

- 2025-09: MXN 19.22 per share

- 2025-10: MXN 18.14 per share

- 2025-11: MXN 18.74 per share

- 2025-12: MXN 17.91 per share

- 2026-01: MXN 16.63 per share

- 2026-02: MXN 18.28 per share

- 2026-03: MXN 18.16 per share

- 2026-04: MXN 16.43 per share

- 2026-05: MXN 15.96 per share

- 2026-06: MXN 14.98 per share

- 2026-07: MXN 14.67 per share

- 2026-08: MXN 13.17 per share

- 2026-09: MXN 12.51 per share

- 2026-10: MXN 13.31 per share

## Annual estimated value (MXN per share)

- FY2017: low MXN 9.27 per share, central MXN 10.06 per share, high MXN 11.02 per share

- FY2018: low MXN 8.39 per share, central MXN 9.07 per share, high MXN 9.90 per share

- FY2019: low MXN 2.24 per share, central MXN 2.39 per share, high MXN 2.58 per share

- FY2020: low MXN 10.56 per share, central MXN 11.39 per share, high MXN 12.39 per share

- FY2021: low MXN 10.00 per share, central MXN 10.85 per share, high MXN 11.88 per share

- FY2022: low MXN 12.04 per share, central MXN 13.88 per share, high MXN 15.23 per share

- FY2023: low MXN 11.59 per share, central MXN 12.64 per share, high MXN 13.81 per share

- FY2024: low MXN 16.39 per share, central MXN 20.90 per share, high MXN 23.03 per share

- FY2025: low MXN 16.75 per share, central MXN 21.56 per share, high MXN 23.69 per share

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

Prior published observations retained from 2026-10-15T06:51:17.442Z where newer inputs omit a numeric field or fiscal period.

## Sources

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.